Gynuity Health Projects

Resources

Resources by Topic

Postpartum Hemorrhage (View all)

Misoprostol in the management of the third stage of labour in the home delivery in Gambia

Postpartum Hemorrhage: A Challenge for Safe Motherhood

Misoprostol for prevention of postpartum hemorrhage

Postpartum hemorrhage

Treatment of postpartum hemorrhage with misoprostol

Prevention of postpartum hemorrhage with misoprostol

Blood Loss After Vaginal Delivery

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Fever after treatment of postpartum hemorrhage

Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan

Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

High fever following postpartum administration of sublingual misoprostol

What measured blood loss tells us about postpartum bleeding

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Misoprostol to augment routine active management of the third stage of labor

Misoprostol for Treatment of Postpartum Hemorrhage

Postpartum hemorrhage: Moving from Research to Reality

The Product Problem:  Pathways for Making Misoprostol Available for Postpartum Hemorrhage

Misoprostol for postpartum hemorrhage: Moving from evidence to practice

Advance misoprostol distribution for preventing and treating postpartum haemorrhage

Misoprostol for the prevention and treatment of postpartum hemorrhage

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage

Controlled cord traction in active management of the third stage of labour (comment)

Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?

Misoprostol for the management of postpartum bleeding: A new approach

Sublingual Misoprostol for the Treatment of Postpartum Hemorrhage

How effective are the components of active management of the third stage of labor?

A new formulation of misoprostol is unlikely to revolutionise postpartum haemorrhage care

Treatment for primary postpartum haemorrhage

WHO Multicountry Survey on Maternal and Newborn Health Research Network

Evidence versus influence in the WHO procedure for approving essential medicines

Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss

Self-Administration of Misoprostol for Prevention of Postpartum Hemorrhage (PPH)

Misoprostol added to the WHO Model List of Essential Medicines for the Treatment of PPH

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Secondary Prevention/Early Treatment of PPH

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Misoprostol for Postpartum Hemorrhage: Questions and Answers for Policy Makers

Oxytocin in Uniject™ versus misoprostol for prevention of postpartum hemorrhage at the community

Oxytocin via Uniject versus oral misoprostol for prevention of postpartum haemorrhage

Misoprostol for primary versus secondary prevention of postpartum haemorrhage

A systematic review of the relationship between blood loss and clinical signs.

Revised And Expanded Guidance On Misoprostol-only Recommended Regimens

Postpartum Hemorrhage Prevention in Nepal: A Program Assessment

Achieving community-based postpartum follow up in eastern Uganda

Intravenous Versus Intramuscular Oxytocin for the Prevention of PPH

WHO Model List of Essential Medicines for Treatment of Incomplete Abortion and miscarriage